CCL2 and stroke disorder: These findings add to the existing body of basic science (Georgakis, van der Laan, et al., 2021), observational (Georgakis, De Lemos, et al., 2021; Georgakis, van der Laan, et al., 2019b), and genetic evidence (Georgakis, Gill, et al., 2019) implicating circulating MCP‐1 in stroke risk.